Medicube
US$ 28.87
does ghk-cu cause tolerance or reduced efficacy over time How Long Last? Half-Life, Results & Shelf Life Effect of GHK-Cu, CuSO4, GHK+CuSO4,
Description
The development and delivery of anti-angiogenic drugs are a large, exciting area of current research that has been reviewed elsewhere (Nishida et al., 2006
Weeks 78 (taper) + 24 week washout: reduce to 200 mcg/day for final week, then pause
We see ourselves as partners in the scientific process
Critical component in peptide research protocols requiring precise dosing and contamination prevention
